Clorpheniramin 4 DHG treatment of allergic rhinitis, runny nose (10 blisters x 20 tablets)
Dosage form Tablet
Specifications Box of 10 blisters x 20 tablets
Ingredient Chlorpheniramin Maleat
Indication Rhinitis, allergic rhinitis, urticaria, itching, stuffy nose
Ingredient
| Composition information | Content |
| Chlorpheniramin Maleat | 4mg |
Uses
Indications
Clorpheniramin 4mg is indicated in the following cases:
pharmacokinetic
absorption
chlorpheniramine maleaty absorbs well by oral, appears in plasma within 30 - 60 minutes and reaches the peak concentration in plasma after 2.5 - 6 hours.
Distribution
About 70% of the drug during the circulation associated with plasma proteins.
Elimination
The drug is excreted mainly in urine in a constant or metabolic form. The excretion depends on pH and urine flow. The sale time of chlorpheniramine is 12 - 15 hours.
Before taking Clorpheniramin 4 DHG treatment of allergic rhinitis, runny nose (10 blisters x 20 tablets)
How to use
Clorpheniramin 4mg orally.
Dosage
Adults and children over 12 years: take 1 capsule, go to bed, no more than 6 capsules/day.
Elderly: Use 4 mg, divide 2 times/day.
Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.
What to do when overdose?
Expressions of overdose: sedation, mental disorder, seizure, apnea, convulsions, anti -secretion effects Acetyicholine, hypertonic and cardiovascular disorder reaction, arrhythmia.
How to handle: Gastrointestinal or vomiting with ipecacuanha syrup. Then, use activated carbon or bleach to limit absorption. When experiencing hypotension and arrhythmia, it should be actively treated. It is possible to treat convulsions with intravenous diazepam or phenytoin intravenously. May have to be blood transfusion in heavy cases.
What to do when forgetting a dose? However, if close to the next dose, skip the forgotten dose and take the next dose at the time as planned. Note that it should not be used double the prescribed dose.
Side Effects
When using Clorpheniramin 4, you may experience unwanted effects (ADR).
Common, ADR> 1/100
No report.
Rare, 1/10000 When experiencing side effects of Clorpheniramin, it is necessary to stop using and notify the doctor or go to the nearest medical facility for timely treatment.
Warnings
Before using the drug you need to read the instructions carefully and refer to the information below.
Contraindicated
Clorpheniramin 4 contraindications in the following cases:
Caution when using
chlorpheniramine may increase the risk of urinary retention, especially in people with prostate hypertrophy, urinary tract, pyloric giropic, and exacerbate in patients with myasthenia gravis.
The sedative effect of chlorpheniramine increases when drinking alcohol and when used simultaneously with other sedatives.Be cautious when taking chlorpheniramin 4mg for people with chronic lung disease, briefly or shortness of breath because of the risk of respiratory complications, respiratory decline and apnea.
The risk of tooth decay in patients treated for a long time.
Avoid using patients with glaucoma like glaucoma.
Be cautious when taking chlorpheniramin for the elderly.
The ability to drive and operate machinery
to avoid being used for people who are driving or operating machinery.
Pregnancy
only use drugs for pregnant women when really necessary. Do not take the drug in the last 3 months of pregnancy.
Breastfeeding period
Should consider not to breastfeed or do not take the drug, depending on the degree of need for the drug for the mother.
Drug interaction
chlorpheniramine inhibits phenytoin metabolism, which can lead to phenytoin poisoning.
Sedapic drugs that cause sleep, alcoholic beverages can increase the effect of inhibiting the central nervous system of chlorpheniramine.
Monoamine oxidase inhibitors prolonged and increased the anti -secretion effect of acetylcholine of antihistamine drugs.
Storage
In a dry place, the temperature does not exceed 30 ° C, avoiding light.
Other drugs
- BRICANYL 0.3 MG/ML SYRUP
- CALCIMAX SYRUP
- CHLORPHENAMINE 10MG/ML SOLUTION FOR INJECTION
- CO-AMOXICLAV 250/62.5MG/5ML POWDER FOR ORAL SUSPENSION
- CEPOREX TABLETS 1G
- Pantoloc Control
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions